Phenotypic chemical screening using zebrafish neural crest reporters identifies retinoid acid as an inhibitor of epithelial morphogenesis

Laura Jiménez, Jindong Wang, Monique Morrison, Clifford J. Whatcott, Katherine K. Soh, Steven L. Warner, David J. Bearss, Cicely A. Jette, Rodney A. Stewart

TL;DR

This paper introduces a novel zebrafish reporter line, Tg(snai1b:GFP), for real-time, whole-animal screening of compounds that inhibit epithelial-to-mesenchymal transition (EMT) during neural crest development. They identified TP-0903, a multi-kinase inhibitor, which surprisingly acts by activating retinoic acid (RA) signaling, revealing RA as a potent inhibitor of EMT and suggesting a new therapeutic avenue for cancer metastasis.

What Problem Does This Paper Address?

The epithelial-to-mesenchymal transition (EMT) is a fundamental biological process crucial for embryonic development, tissue regeneration, and unfortunately, cancer metastasis. In cancer, EMT allows tumor cells to detach, invade, and spread, leading to relapse and poor patient outcomes. Identifying effective inhibitors of EMT is therefore a critical goal for cancer therapy. However, current methods for discovering these inhibitors often rely on in vitro cell-based assays that don't fully recapitulate the complex in vivo environment, potentially missing compounds that are effective in a whole organism. Furthermore, the precise signaling pathways that control EMT during development, particularly in the context of neural crest (NC) cell formation, are not fully understood, hindering the rational design of targeted therapies. This paper aims to address these limitations by developing a robust in vivo screening platform in zebrafish to identify novel EMT inhibitors and to elucidate the underlying mechanisms.

Methods

The core innovation of this study is the development of a transgenic zebrafish line, Tg(snai1b:GFP). This line uses a ~3kb fragment of the snailb promoter to drive GFP expression in epithelial cells that are undergoing EMT to become neural crest (NC) cells. This allows for direct visualization of EMT in real-time within a living embryo.

Key techniques employed include:

  • Whole-mount in situ hybridization (WISH): Used to compare the expression pattern of the reporter transgene (GFP) with endogenous snailb mRNA, confirming the reporter's accuracy.
  • Confocal microscopy and time-lapse imaging: Essential for observing dynamic cellular behaviors like delamination, migration, and morphological changes associated with EMT in live embryos.
  • Generation of double-transgenic lines: Combining Tg(snai1b:GFP) with a previously established NC reporter line, Tg(sox10:mRFP), allowed for co-visualization of different stages of NC development and EMT.
  • Chemical screening: A pilot screen was conducted by treating Tg(snai1b:GFP) embryos with a library of kinase inhibitors to identify compounds that blocked EMT, visualized by the accumulation of GFP-positive cells within the neural tube.
  • RNA sequencing (RNA-Seq): Performed on embryos treated with the identified inhibitor (TP-0903) to understand its molecular mechanism of action.
  • Chemical rescue experiments: Used to confirm the role of specific signaling pathways, such as retinoic acid (RA) synthesis, in mediating the observed effects.
  • Immunofluorescence: Used to examine protein expression, such as E-cadherin, to assess changes in cell adhesion during EMT.

Datasets

Not discussed in the paper.

Key Insights and Ideas

  • Dual origin of cranial neural crest: The study provides strong evidence for two distinct origins of cranial NC cells in zebrafish: an earlier population delaminating from the non-neural ectoderm adjacent to the neural keel, and a later population emerging from within the dorsal neural tube. This dual origin has been suggested in other vertebrates but is clearly visualized here.
  • Tg(snai1b:GFP) as a superior EMT reporter: This reporter line labels cells earlier in the EMT process (progenitors within the neural tube) compared to existing NC reporters (which label more migratory cells), making it ideal for identifying inhibitors of the initial epithelial morphogenesis steps.
  • Retinoic acid as a potent EMT inhibitor: The most surprising finding is that TP-0903, a multi-kinase inhibitor, functions by activating retinoic acid (RA) signaling. This reveals RA as a critical endogenous inhibitor of EMT and NC cell migration, a role previously overlooked.
  • RA's multifaceted role in NC development: RA appears to control multiple aspects of cranial NC development, including delamination, collective cell migration, and ectomesenchymal differentiation.
  • Implications for cancer therapy: The discovery that RA can antagonize EMT-dependent programs suggests that activating RA signaling could be a viable strategy to inhibit cancer metastasis and potentially reverse mesenchymal transcriptional programs in cancer stem cells.

Key Results

  • The Tg(snai1b:GFP) reporter line successfully visualized cranial NC cell delamination from two distinct regions in zebrafish embryos.
  • A pilot chemical screen identified TP-0903 as a potent inhibitor of cranial NC EMT and cell migration in vivo.
  • TP-0903 treatment led to the accumulation of GFP-positive cells within the dorsal neural tube, indicating a block in EMT.
  • RNA-Seq analysis revealed that TP-0903 rapidly induces retinoic acid (RA) signaling, activating RA-target genes and canonical RA pathways.
  • Chemical rescue experiments with DEAB (an RA synthesis inhibitor) demonstrated that TP-0903's effects are dependent on RA biosynthesis.
  • Direct treatment with RA mimicked the effects of TP-0903, inhibiting EMT, cell migration, and ectomesenchymal differentiation (e.g., reducing dlx2a expression).
  • TP-0903 also reversed mesenchymal features in human cancer cells in vitro, validating its efficacy as an EMT inhibitor.

Limitations and Future Work

  • Off-target effects of TP-0903: While TP-0903 was identified as a multi-kinase inhibitor, the study notes that inhibiting single targets was insufficient to recapitulate the observed NC EMT phenotypes, suggesting that multiple pathways or unknown targets are involved. Further investigation into the precise molecular targets of TP-0903 is warranted.
  • Fate of lateral NC cells: The study observed aberrant mitfa expression in lateral NC cells treated with TP-0903, suggesting a potential fate change or differentiation into non-ectomesenchymal lineages. Future work should involve detailed fate-mapping studies to fully understand the consequences of RA signaling on these cells.
  • Retinoid resistance: The authors acknowledge that retinoid resistance is a clinical challenge. The identification of TP-0903 as a compound that activates RA signaling through a novel mechanism offers a potential avenue to overcome this resistance and improve retinoid-based therapies.
  • Clinical translation: The paper mentions that TP-0903 is progressing towards clinical trials, suggesting future work will focus on its therapeutic potential in patients, particularly for advanced malignancies.
  • Broader application of the reporter: The Tg(snai1b:GFP) line and screening assay are presented as valuable tools for identifying other EMT inhibitors, including those that might disrupt epithelial morphogenesis programs beyond cell migration. Future work could involve screening larger compound libraries and exploring combinations of inhibitors.

Summary updated

Abstract

The epithelial-to-mesenchymal transition (EMT) is a highly conserved morphogenetic program essential for embryogenesis, regeneration and cancer metastasis. In cancer cells, EMT also triggers cellular reprogramming and chemoresistance, which underlie disease relapse and decreased survival. Hence, identifying compounds that block EMT is essential to prevent or eradicate disseminated tumor cells. Here, we establish a whole-animal-based EMT reporter in zebrafish for rapid drug screening, calledTg(snai1b:GFP), which labels epithelial cells undergoing EMT to producesox10-positive neural crest (NC) cells. Time-lapse and lineage analysis ofTg(snai1b:GFP)embryos reveal that cranial NC cells delaminate from two regions: an early population delaminates adjacent to the neural plate, whereas a later population delaminates from within the dorsal neural tube. TreatingTg(snai1b:GFP)embryos with candidate small-molecule EMT-inhibiting compounds identified TP-0903, a multi-kinase inhibitor that blocked cranial NC cell delamination in both the lateral and medial populations. RNA sequencing (RNA-Seq) analysis and chemical rescue experiments show that TP-0903 acts through stimulating retinoic acid (RA) biosynthesis and RA-dependent transcription. These studies identify TP-0903 as a new therapeutic for activating RAin vivoand raise the possibility that RA-dependent inhibition of EMT contributes to its prior success in eliminating disseminated cancer cells.
BibTeX
@inproceedings{jimenez2016phenotypic,
  author = {Laura Jiménez and Jindong Wang and Monique Morrison and Clifford J. Whatcott and Katherine K. Soh and Steven L. Warner and David J. Bearss and Cicely A. Jette and Rodney A. Stewart},
  title = {{Phenotypic chemical screening using zebrafish neural crest reporters identifies retinoid acid as an inhibitor of epithelial morphogenesis}},
  booktitle = {Disease},
  year = {2016},
  doi = {10.1242/dmm.021790},
}
Figure